Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers

Safa Hoodeshenas¹, Jonathan R Dillman¹, Stuart A Taylor¹+13

• ¹From the Department of Radiology (S.H., K.A.R., A.L., D.J.B., A.H.G., S.C., J.G.F.), Division of Gastroenterology and Hepatology (D.H.B.), and Department of Laboratory Medicine and Pathology (C.E.H.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; Department of Radiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio (J.R.D.); Center for Medical Imaging, University College London, London, UK (S.A.T.); IBD Unit, Department of Radiology, Hospital Clínic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain (J.R.); Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (B.T.); Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio (F.R.); Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute and Program for Global Translational Inflammatory Bowel Disease Research, Cleveland Clinic, Cleveland, Ohio (F.R.); Alimentiv, London, Ontario, Canada (B.F.); Department of Medicine and Department of Epidemiology and Statistics, University of Western Ontario, London, Ontario, Canada (B.F.); and Imaging Institute, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, Ohio (M.E.B.).